Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon M Hanifin

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Journal of the American Academy of Dermatology|March 25, 2008
Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicleDebra Breneman, Alan B Fleischer, William Abramovits, et al.
The Journal of Investigative Dermatology|June 29, 2005
Cell death-induced activation of epidermal growth factor receptor in keratinocytes: implications for restricting epidermal damage in dermatitisMihail S Iordanov, Aaron J Sundholm, Eric L Simpson, et al.
The Journal of Investigative Dermatology|August 14, 2016
Validation and Banding of the ItchyQuant: A Self-Report Itch Severity ScaleCaitlin G Haydek, Elyse Love, Nicholas K Mollanazar, et al.
Nature Medicine|August 9, 2005
Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypoxErika Hammarlund, Matthew W Lewis, Shirley V Carter, et al.
Journal of the American Academy of Dermatology|May 19, 2016
OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled studyJon M Hanifin, Charles N Ellis, Ilona J Frieden, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2017
A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitisDonald Y M Leung, Brett Jepson, Lisa A Beck, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2014
Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis preventionEric L Simpson, Joanne R Chalmers, Jon M Hanifin, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 22, 2010
Quantitative risk assessment of contact sensitization: clinical data to assess utility of the modelAnne Marie Api, Donald Belsito, David Bickers, et al.
Journal of the American Academy of Dermatology|February 28, 2004
Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines"Jon M Hanifin, Kevin D Cooper, Vincent C Ho, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 19, 2016
A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus OpinionJennifer K Chen, Sharon E Jacob, Susan T Nedorost, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Journal of the American Academy of Dermatology|March 25, 2008
Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicleDebra Breneman, Alan B Fleischer, William Abramovits, et al.
The Journal of Investigative Dermatology|June 29, 2005
Cell death-induced activation of epidermal growth factor receptor in keratinocytes: implications for restricting epidermal damage in dermatitisMihail S Iordanov, Aaron J Sundholm, Eric L Simpson, et al.
The Journal of Investigative Dermatology|August 14, 2016
Validation and Banding of the ItchyQuant: A Self-Report Itch Severity ScaleCaitlin G Haydek, Elyse Love, Nicholas K Mollanazar, et al.
Nature Medicine|August 9, 2005
Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypoxErika Hammarlund, Matthew W Lewis, Shirley V Carter, et al.
Journal of the American Academy of Dermatology|May 19, 2016
OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled studyJon M Hanifin, Charles N Ellis, Ilona J Frieden, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2017
A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitisDonald Y M Leung, Brett Jepson, Lisa A Beck, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2014
Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis preventionEric L Simpson, Joanne R Chalmers, Jon M Hanifin, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 22, 2010
Quantitative risk assessment of contact sensitization: clinical data to assess utility of the modelAnne Marie Api, Donald Belsito, David Bickers, et al.
Journal of the American Academy of Dermatology|February 28, 2004
Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines"Jon M Hanifin, Kevin D Cooper, Vincent C Ho, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 19, 2016
A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus OpinionJennifer K Chen, Sharon E Jacob, Susan T Nedorost, et al.
Pageof 8